跳至主要内容
临床试验/CTRI/2022/07/043836
CTRI/2022/07/043836尚未招募2 期

ROLE OF ROHITAKADI VATI IN YAKRITA VIKARA (NON-ALCOHOLIC FATTY LIVER DISEASE)

Dr Shweta Rawat1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2022年11月7日最近更新:
适应症

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
30
试验地点
1
主要终点
Improvement in sign and symptoms of Yakrita Vikara (Non-alcoholic fatty liver disease) are Aruchi, Avipaka, Hrillasa, Daurbalya, Udara shoola, Asya-vairsya, Anaha.

研究概览

简要总结

In Ayurveda,Liver play an important role as Chaya-upachayay, Ranjana of Rasa Dhatu, Storage and detoxification to keep body healthy. Due to Western Lifestyle Disorders, Agni play major role in manifestation of diseases such as Yakrita vikara (Non-alcoholic fatty liver disease). Ayurveda describes Liver disease in context of Yakrita Vikara . These concepts can be applied to fatty liver also. Nowadays NAFLD so common. Symptoms are loss of appetite, Indigestion, Nausea, Abdominal pain, Altered taste in mouth. The drug chosen for study is Rohitakadi vati described in Bhaishajya Ratnavali having Rechana *Purgative), Lekhana, Agnivardhaka, Ama, Medha Kapha nasak qualities.

研究设计

研究类型
Interventional
分配方式
Not Applicable
盲法
Not Applicable

入排标准

年龄范围
20.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • •1.Patients with clinical sign and symptom of Yakrita Vikara (Non-alcoholic fatty liver disease) are Aruchi, Hrillasa, Avipaka, Daurbalya, Udara shoola, Asya-vairasya, Anaha.
  • •Fatty Liver Grade-1 and Grade-2 based on USG.
  • •Liver function test showing raised Alanine amini transferase more than 1.5 times the normal limits.
  • •Prediabetic patients.

排除标准

  • •1.Age group <20 years and >60 years.
  • •2.Chronic Renal Failure, Ischemic heart disease, Congestive cardiac failure, Liver cirrhosis, AIDS.
  • •3.Pregnancy and Lactation.
  • •4.Prolonged medication for various systemic disorders.
  • •Grade-3 Fatty Liver.

结局指标

主要结局

Improvement in sign and symptoms of Yakrita Vikara (Non-alcoholic fatty liver disease) are Aruchi, Avipaka, Hrillasa, Daurbalya, Udara shoola, Asya-vairsya, Anaha.

时间窗: 3 weeks

次要结局

  • Improvement in Liver function test and USG.(60 days)

研究者

发起方
Dr Shweta Rawat
申办方类型
Other [self]

研究点 (1)

Loading locations...

相似试验